Sanj K Patel Net Worth & Insider Trades

Sanj K Patel - Chairman & CEO, Kiniksa Pharmaceuticals, Ltd

As of March 18, 2022

What is Sanj K Patel's Net Worth?

The current estimated net worth of Kiniksa Pharmaceuticals, Ltd's Chairman & CEO, Sanj K Patel, is estimated to be about $9.09M . Sanj K Patel owns about 193,131 units of Kiniksa Pharmaceuticals, Ltd common stock. In the last 4 years at Kiniksa Pharmaceuticals, Ltd, Sanj K Patel has sold an estimated value of $7.26M worth.

What is Sanj K Patel's Past Insider Trading?

Sanj K Patel's largest purchase order was 151,572 units , worth over $241K on October 14, 2020. Sanj K Patel's largest sale order was 251,572 units , worth over $5.29M on October 14, 2020. In total, Sanj K Patel has made about 12 transactions over 4 years of their time at Kiniksa Pharmaceuticals, Ltd. Sanj K Patel usually trades in March, with the busiest year in 2020 and 2021. The most recent transaction was a sale order of 56,159 units , worth over $1.29M on February 10, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Sanj K Patel's Salary in 2020?

As Chairman & CEO of Kiniksa Pharmaceuticals, Ltd, Sanj K Patel has a total base salary of $780,000 . Sanj K Patel received compensation valued at about $5,313,564 in 2020 after becoming Chairman & CEO. The vast majority of their compensation came in the form of other earnings, plans or compensations of $633,750 , option awards of $3,888,414 , other earnings, plans or compensations of $633,750 , and other compensation of $11,400 .

What is Sanj K Patel's' Mailing Address?

  • Mailing address is C/o Kiniksa Pharmaceuticals, Ltd. Clarendon House, 2 Church Street Hamilton D0 HM11 Bermuda

Kiniksa Pharmaceuticals, Ltd Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Sanj K. Patel 2020 $780,000 $633,750 $3,888,414 $633,750 $11,400 $5,313,564
Sanj K. Patel 2019 $780,000 $456,300 $3,518,171 $456,300 $11,200 $4,765,671
Thomas Beetham 2020 $440,000 $220,000 $1,620,173 $220,000 $11,400 $2,291,573
Qasim Rizvi, MBChB., MBA 2020 $431,970 $188,987 $1,620,173 $188,987 $11,400 $2,252,530
Qasim Rizvi, MBChB., MBA 2019 $392,700 $123,701 $880,884 $123,701 $11,200 $1,503,573
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1730430/000110465921056540/tm212498-1_def14a.htm

What are Kiniksa Pharmaceuticals, Ltd's Past Insider Trades?

Kiniksa Pharmaceuticals, Ltd's most recent insider trade came on February 10, 2021 by Sanj K Patel who sold 56,159 units worth $1.29M . In the last 3 years, insiders at Kiniksa Pharmaceuticals, Ltd have sold an estimated value of $10.44M and bought an estimated value of $71.86M worth of shares. Insider trading is most common in March, with the busiest year in 2022. The most active traders at the company are John Paolini, CHIEF MEDICAL OFFICER,  Sanj Patel, CHAIRMAN & CEO,  and Thomas W Beetham, EVP & Chief Legal Officer .

Kiniksa Pharmaceuticals, Ltd. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1